Search
Feedback
About UniCat 
Help
News
| Listing 1 - 10 of 76 | << page >> |
Sort by
|
ISBN: 088831096X Year: 1981 Publisher: Montreal Eden press
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
ISBN: 0888310536 Year: 1979 Publisher: Montreal Eden press
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1966 Publisher: New York (N.Y.): McGraw-Hill
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
ISBN: 0920792146 Year: 1982 Publisher: Montreal Eden press
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1980 Publisher: Edinburgh Churchill Livingstone
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
ISBN: 0443018375 Year: 1979 Publisher: Edinburgh Churchill Livingstone
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
ISBN: 0888310056 Year: 1977 Publisher: Montreal Eden press
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1982 Publisher: New York (N.Y.): Biomedical corporation publ.
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 2014 Publisher: Bruxelles: UCL. Faculté de pharmacie et des sciences biomédicales,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
The estrogen plus progestin contraception is associated with an increased risk of venous thromboemlism. Although the relative risk is significant, the absolute risk is generally low unless there are superimposedfactors or associated conditions (pregnancy, thrombophilia. obesity...).A blood test .for the detection of abnormalities of haemostasis shall be suggested for each case where a person suffering from thrombophilia.What are the predisposing factors for thrombophilia ? Although the incidence of thrombophilia is low in the general population, it may be responsible for death. Although the estrogen plus progestin contraception is the most commonly used contraceptive in Belgium other contraceptive methods seem interesting from the point of view of thromboembolic risk La contraception oestroprogestative est associée à une augmentation du risque de maladie thromboembolique veineuse. Même si le risque relatif est significatif, le risque absolu est généralement faible à moins qu'il n'existe desfacteurs surajoutés ou des conditions associées (grossesse, thrombophilie, obésité, ...) Un dépistage sanguin permettant la détection des anomalies de l 'hémostase sera proposé au cas par cas chez une personne atteinte de thrombophilie. Quels sont lesfacteurs prédisposant à une thrombophilie? Bien que l'incidence de thrombophilie soit faible dans lapopulation générale, elle peut être responsable de décès.Malgré que, la contraception oestroprogestative soit la méthode contraceptive laplus utilisée en Belgique, d'autres méthodes contraceptives semblent intéressantes du point de vue des risques thromboemboliques.
Contraceptives, Oral, Combined --- Contraceptives, Oral, Combined --- Thrombophilia
Book
Year: 2014 Publisher: Bruxelles: UCL. Faculté de pharmacie et des sciences biomédicales,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
La femme en âge de procréer est soumise à un cycle menstruel de 28 jours. Durant la période ovulatoire, le risque d’une grossesse est important. Différents moyens s’offrent donc à elle afin de l’éviter. La contraception hormonale orale combinée est aujourd’hui la méthode la plus utilisée dans le monde. La combinaison d’œstrogène et d’un progestatif permet un blocage du fonctionnement ovarien des différentes manières. Cette contraception a connu bien des évolutions depuis sa découverte en 1960, non seulement pour améliorer le confort de la femme mais également pour diminuer les risques (majoritairement cardiovasculaires) liés à l’utilisation de la pilule contraceptive. L’une de ces évolutions a porté sur le progestatif utilisé. Ceux-ci sont désignés en termes de générations et les deux dernières générations (troisième et quatrième) semblent augmenter le risque de thromboembolie veineuse. Le but de ce travail est d’étudier les raisons qui sous-tendent l’évolution des pilules contraceptives ainsi que d’analyser différentes études pour mieux cerner la vérité concernant ces nouvelles pilules. Women old enough to procreate are submitted to a natural menstrual cycle of 28 days long. During ovulatory period, the risk of becoming pregnant is very high. Various ways of preventing pregnancy can by used. Today, the combined oral-hormonal contraception is the most used method. The combination of an oestrogen and a progestogen can block ovarian functioning in various ways. This contraception has evolved since its discovery in 1960. Those innovations do not only improve the comfort of the woman but also to decrease the risks (mainly cardiovascular) due to the use of the contraceptive pill. One of these stages of evolution was about the types of progestogen that could be effective. They are known in terms of generations and the two last ones (third and fourth) would seem to increase the risk of venous thromboembolism. The aim if this final paper is to study the underlying reasons of the contraceptive pill’s evolution as well as analyze various studies in order to finally know the truth about these new pills.
| Listing 1 - 10 of 76 | << page >> |
Sort by
|